Journal Information

Statistics

Follow this link to access the full text of the article

Research Letter
Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction
O início do tratamento com sacubitril-valsartan é seguro em doentes com amiloidose cardíaca transtirretina e fração de ejeção reduzida
Martin Negreira-Caamañoa, Jorge Martínez-Del Ríoa, Alfonso Morón-Alguacila, Pedro Pérez-Díaza,b, Jesus Piqueras-Floresa,b,c,
Corresponding author
jesus.piqueras.flores@gmail.com

Corresponding author.
a Cardiology Department, University General Hospital of Ciudad Real, Spain
b Cardiomyopathies and Inherited Disease Unit, Cardiology Department, University General Hospital of Ciudad Real, Spain
c Medicine Faculty, Castilla La-Mancha University, Ciudad Real, Spain
Read
4018
Times
was read the article
1244
Total PDF
2774
Total HTML
Share statistics
Article information
ISSN: 08702551
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 11 221 58 279
2025 10 198 67 265
2025 9 136 44 180
2025 8 150 66 216
2025 7 118 55 173
2025 6 80 28 108
2025 5 149 38 187
2025 4 100 43 143
2025 3 98 22 120
2025 2 75 19 94
2025 1 60 30 90
2024 12 64 38 102
2024 11 80 39 119
2024 10 69 54 123
2024 9 85 41 126
2024 8 70 39 109
2024 7 52 26 78
2024 6 40 34 74
2024 5 49 27 76
2024 4 50 29 79
2024 3 46 28 74
2024 2 51 26 77
2024 1 33 18 51
2023 12 33 22 55
2023 11 56 39 95
2023 10 49 12 61
2023 9 42 27 69
2023 8 53 15 68
2023 7 65 15 80
2023 6 62 12 74
2023 5 70 39 109
2023 4 58 21 79
2023 3 67 24 91
2023 2 91 84 175
2023 1 39 32 71
2022 12 15 33 48
Show all

Follow this link to access the full text of the article

Idiomas
Revista Portuguesa de Cardiologia (English edition)
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.